Advanced manufacturing
Amgen Holly Springs Second Manufacturing Facility
Holly Springs, North Carolina
Project overview
Amgen announced a second drug substance manufacturing facility at Holly Springs with an additional $1 billion investment. This record tracks the expansion, separate from the first facility that opened in January 2025.
- Scope
- Amgen announced a second drug substance manufacturing facility at Holly Springs with an additional $1 billion investment. This record tracks the expansion, separate from the first facility that opened in January 2025.
- Project type
- Biopharmaceutical manufacturing
- Reported investment / scope
- Not available
- Funding sources
- Not available
- Delivery method
- Not available
Organizations involved
- Owner / developer
- Amgen
- Developer
- Not available
- Engineering firm / architect
- Not available
- General contractor / construction manager
- Not available
- EPC contractor
- Not available
- Technology / equipment providers
- Not available
- Financial sponsor
- Not available
- Other recorded participants
- Not available
Business opportunities
Not verified
- Current procurement record
- Not available
- Upcoming procurement
- Not available
- Contract / package value
- Not available
- Supplier / subcontractor opportunities
- Not available
- Workforce requirements
- Not available
Check official project / procurement portal ↗
A project listing is not an open solicitation. Check the source for eligibility, current status, closing time and addenda.
Timeline & key dates
- Expected procurement
- Not available
- Construction start
- Not available
- Estimated completion
- Not available
- Dated milestones
- Not available
- Permitting
- Not available
- Recent project updates
- Added October 1, 2026. Schedule targets reflect the linked source; map location is approximate.
- Challenges / risks
- Not available
Related intelligence
No verified record associations have been entered for this project yet.
Connections use recorded entity IDs and public evidence. Shared keywords do not establish a relationship.
Additional project record
Amgen announced a second drug substance manufacturing facility at Holly Springs with an additional $1 billion investment. This record tracks the expansion, separate from the first facility that opened in January 2025.
Owner: Amgen. Stage: Planning. Location: Holly Springs, North Carolina.
Official project source. Reviewed October 1, 2026.
Saved searches & recent searches
Sign in to keep searches across devices. Your recent searches on this device appear below.
Join Infraday Free · Sign in